Sept. 28, 2023 – Following greater than a dozen stories of intestinal blockages amongst folks utilizing the diabetes drug Ozempic, the FDA introduced that the possibly life-threatening situation can be listed on the drug’s label.
The medical time period for intestinal blockage is “ileus,” and 18 instances of it in folks taking Ozempic have been reported to the FDA.
The FDA has obtained greater than 8,500 stories of gastrointestinal points amongst folks taking medicines like Ozempic and Wegovy, the latter of which is accredited for weight reduction. Ileus is talked about in 33 instances, together with two deaths, of individuals taking medicine containing semaglutide, which is the energetic ingredient in Ozempic, Wegovy, and one other extensively used weight reduction drug known as Mounjaro.
Semaglutide works by mimicking a hormone known as glucagon-like peptide-1 (GLP-1) that targets mind areas that regulate urge for food and meals consumption. The labels for Mounjaro, Ozempic, and Wegovy already point out that delayed abdomen emptying can happen. Vital weight reduction is related to taking semaglutide, usually within the vary of 15% of physique weight.
The FDA stopped wanting saying there’s a direct hyperlink between Ozempic and intestinal blockages.
“As a result of these reactions are reported voluntarily from a inhabitants of unsure dimension, it’s not at all times potential to reliably estimate their frequency or set up a causal relationship to drug publicity,” the FDA stated in its approval of the label replace.
The identical warning for the danger of intestinal blockages is already listed on the labels for Mounjaro and Wegovy.
The label change comes after a Louisiana lady filed a lawsuit in August that claims she was “severely injured” after utilizing Mounjaro and Ozempic and that the pharmaceutical corporations didn’t disclose the medicine’ danger of inflicting vomiting and diarrhea on account of irritation of the abdomen lining, in addition to the danger of abdomen paralysis (generally known as gastroparesis.)
